Catecholamine-induced vasoconstriction is sensitive to carbonic anhydrase I activation

Area of Science:

• Biochemistry
• Physiology
• Pharmacology

Background:

• Adrenergic agonists are key regulators of physiological processes.
• Carbonic anhydrase isozymes (I and II) play vital roles in cellular functions.
• The interplay between adrenergic signaling and carbonic anhydrase activity requires further elucidation.

Purpose of the Study:

• To investigate the effect of alpha- and beta-adrenergic agonists on carbonic anhydrase I and II activity in erythrocytes.
• To examine the relationship between adrenergic agonist-induced carbonic anhydrase activation and physiological responses, including blood pressure and vasoconstriction.

Main Methods:

• Kinetic studies were performed to analyze enzyme activity.
• Erythrocyte, clinical, and isolated vessel studies were conducted.
• Measurements included carbonic anhydrase activity and blood pressure changes.

Main Results:

• Adrenergic agonists (adrenaline, noradrenaline, isoprenaline, orciprenaline) significantly increased erythrocyte carbonic anhydrase activity.
• Kinetic analysis revealed a non-competitive mechanism of action.
• Clinical and vessel studies demonstrated a parallel increase in carbonic anhydrase I and blood pressure, suggesting a role in vasoconstriction.

Conclusions:

• Adrenergic agonists activate carbonic anhydrase I and II in erythrocytes through a non-competitive mechanism.
• A dual mechanism of action is proposed, involving both receptor-mediated signaling and direct carbonic anhydrase activation.
• This activation is essential for maintaining intracellular pH, supporting stimulus-receptor coupling, and mediating vasoconstriction.